NCT00574171 2019-12-18Phase II Trial of Lapatinib & Capecitabine for Patients With Refractory Advanced Colorectal AdenocarcinomaUniversity of Wisconsin, MadisonPhase 2 Completed29 enrolled 6 charts
NCT00536809 2017-12-18Phase I/II Study of Lapatinib in Combination With Oxaliplatin and Capecitabine in Subjects With Advanced Colorectal CancerGlaxoSmithKlinePhase 1 Completed12 enrolled 6 charts